Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis.
about
The synovio-entheseal complex in enthesoarthritis.Osteoimmunology and osteoporosis.ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis.Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) modelProgress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis.Osteoporosis: a paradox in ankylosing spondylitis.The balance of tissue repair and remodeling in chronic arthritis.The role of bone morphogenetic proteins in ankylosing spondylitis.Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis.Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis.Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2 -microglobulin-transgenic rat model of spondylarthritis.Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors.Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis.Bushen Qiangji Granule () medicated serum inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by inhibiting the BMP/Smads signal pathway in vitro.Axial spondyloarthritis.
P2860
Q33360030-CC40F705-0C2E-45FD-9C7F-8FCE91A507E7Q35840701-351A1A49-9BF6-4050-9DFC-63235E90B68CQ36246044-379227D6-BD2F-4F52-8E3B-5AC29AF43AEBQ36493751-96E01F08-78A7-406A-9366-3DA8CD910EC3Q37480069-EF821A25-564B-463E-A485-DAD3A27E2BD5Q37885790-C6548E0F-C539-4A72-AEAD-039D55D4B9E8Q37947117-A3B4C6F3-8951-4E04-8BC7-F94AA1F147C3Q38031830-EF5A4681-EC7F-4351-8B76-7353D54FBE0FQ38071564-6BF30AA7-08D5-4877-8B1E-C0C366677CFFQ38555291-E07AE854-6D51-4509-B4F1-186DD956B208Q41961746-08C5BC8F-B624-4582-A643-6C12F870BABDQ42534690-85DA628D-633C-4E35-8789-46E20F5FE1D9Q43660111-78538ACA-DC36-4B1C-BE6C-D42112EBBBF7Q50436452-0B703663-C95C-4DD3-84A2-142C32D8CBF5Q51122634-D7235C9E-C2A1-455A-845D-4E6A9F5E40F0Q52870848-9E896F66-B7D1-4510-ACF1-00769B0A04AE
P2860
Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Inhibition of osteoclasts does ...... se model of spondyloarthritis.
@en
Inhibition of osteoclasts does ...... se model of spondyloarthritis.
@nl
type
label
Inhibition of osteoclasts does ...... se model of spondyloarthritis.
@en
Inhibition of osteoclasts does ...... se model of spondyloarthritis.
@nl
prefLabel
Inhibition of osteoclasts does ...... se model of spondyloarthritis.
@en
Inhibition of osteoclasts does ...... se model of spondyloarthritis.
@nl
P2093
P356
P1433
P1476
Inhibition of osteoclasts does ...... se model of spondyloarthritis.
@en
P2093
F P Luyten
R J U Lories
P304
P356
10.1093/RHEUMATOLOGY/KEN082
P577
2008-03-11T00:00:00Z